TRACON Pharmaceuticals, Inc.
TCON · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,588 | -$29,135 | -$28,667 | -$16,775 |
| Dep. & Amort. | $0 | $70 | -$59 | -$13 |
| Deferred Tax | $0 | $0 | -$1 | -$1 |
| Stock-Based Comp. | $1,969 | $2,041 | $1,775 | $1,034 |
| Change in WC | -$761 | -$239 | $4,545 | -$1,579 |
| Other Non-Cash | $6,056 | $1,024 | -$164 | $292 |
| Operating Cash Flow | $3,676 | -$26,239 | -$22,571 | -$17,042 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$17 | -$48 | -$5 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$3,998 |
| Inv. Sales/Matur. | $0 | $0 | $4,000 | $0 |
| Other Inv. Act. | $0 | $0 | $4,000 | -$3,998 |
| Investing Cash Flow | $0 | -$17 | $3,952 | -$4,003 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$20,500 | $11,710 | -$2,800 | -$1,400 |
| Stock Issued | $7,916 | $7,879 | $13,211 | $38,162 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $45 | $95 | $149 | $2 |
| Financing Cash Flow | -$12,539 | $19,684 | $10,560 | $36,764 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$8,863 | -$6,572 | -$8,059 | $15,719 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17,500 | $24,072 | $32,131 | $16,412 |
| End Cash | $8,637 | $17,500 | $24,072 | $32,131 |
| Free Cash Flow | $3,676 | -$26,256 | -$22,619 | -$17,047 |